Softwr

Healthcare · head to head

Ibex Medical Analytics vs Rad AI

Ibex Medical Analytics logo

Ibex Medical Analytics

Healthcare

Cancer detection AI for breast, prostate and gastric pathology deployed in routine clinical service, not just pilots

From
On request
Rated
-
Full reviewWebsite
Rad AI logo

Rad AI

Healthcare

Generative reporting and follow-up tracking for radiology, positioned outside the diagnostic device boundary

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Ibex Medical Analytics the European IVDR indication is broader than the United States position, where some applications operate under laboratory developed test arrangements rather than FDA authorisation, which determines whether AI output can influence a signed report.; Rad AI the products are not FDA cleared devices and are not intended to be, so any claim that Rad AI improves diagnostic accuracy is unsupported; what has been measured is reporting speed and follow-up completion, not detection.
  • They diverge on capability: Ibex Medical Analytics covers Ibex Breast Suite, Rad AI covers Impressions.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Ibex Medical Analytics and Rad AI actually diverge.

Attributes where Ibex Medical Analytics and Rad AI differ
AttributeIbex Medical AnalyticsRad AI
PlatformsWeb, Cloud, On-premiseWindows, Web, Cloud

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Ibex Medical Analytics

  • Ibex Breast Suite
  • Ibex Prostate
  • Ibex Gastric
  • Second read safety net
  • Prescreening triage
  • Heatmap localisation
  • Quality reporting
  • Scanner-agnostic ingestion

Only in Rad AI

  • Impressions
  • Reporting
  • Continuity
  • Style learning
  • Omni Reconcile
  • PACS and dictation embedding
  • Patient outreach workflows
  • Audit reporting

What people use each for

The jobs each tool is most often brought in to do.

Ibex Medical Analytics

  • A histopathology department that cannot recruit and wants an automated safety net on every prostate and breast biopsy before sign outnot Rad AI
  • A private laboratory group standardising Gleason grading across pathologists with known interobserver variabilitynot Rad AI
  • A service digitising histopathology that needs a clinical governance argument to justify the scanning programme to its boardnot Rad AI
  • A gastrointestinal service wanting Helicobacter pylori detection automated so pathologists spend their time on the neoplastic casesnot Rad AI

Rad AI

  • A private radiology practice whose read volume has grown faster than it can recruit and that wants dictation time per study reduced without changing PACSnot Ibex Medical Analytics
  • A health system losing revenue and exposing itself to liability because recommended follow-up imaging on incidental findings is never bookednot Ibex Medical Analytics
  • A radiology department standardising impression quality across a mixed group of employed and locum radiologistsnot Ibex Medical Analytics
  • A group deploying an AI tool that must not trigger a device validation programme, because governance capacity is already consumed by a triage algorithm rolloutnot Ibex Medical Analytics

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Ibex Medical Analytics

  • The European IVDR indication is broader than the United States position, where some applications operate under laboratory developed test arrangements rather than FDA authorisation, which determines whether AI output can influence a signed report.
  • It requires a fully digitised histopathology workflow, and slide scanning, storage and validation typically cost several times the algorithm licence.
  • Running it as a second read safety net adds a discrepancy resolution workload that departments consistently underestimate, and someone senior has to adjudicate every flag.
  • Coverage is limited to breast, prostate and gastric, so a general histopathology department still reads the majority of its case mix without any AI support.
  • Pricing is per case and unpublished, so cost scales directly with biopsy volume and does not flatten as the department grows.

Rad AI

  • The products are not FDA cleared devices and are not intended to be, so any claim that Rad AI improves diagnostic accuracy is unsupported; what has been measured is reporting speed and follow-up completion, not detection.
  • Generated impressions require radiologist review and signature, so the time saving evaporates in any group whose radiologists rewrite the draft rather than edit it, and adoption varies sharply by individual.
  • It is bound to your dictation platform, so a group planning to move off PowerScribe should sequence that decision first or expect to redo the Rad AI integration.
  • Continuity depends on the quality of recommendation language in historical reports, and departments with inconsistent phrasing get poor recall until reporting practice is standardised.
  • Pricing is not published and is structured per radiologist or per study depending on the product mix, which makes it hard to compare against image-analysis AI vendors that price per scan.

Pricing, plan by plan

Ibex Medical Analytics

On request
  • Ibex clinical applications$undefined/year
    • Priced per case analysed under an annual agreement
    • Breast, prostate and gastric licensed as separate suites
    • Regulatory indication differs between Europe and the United States

Rad AI

On request
  • Rad AI platform$undefined/year
    • Priced per radiologist or per study volume depending on product and contract
    • Impressions, Reporting and Continuity licensed separately
    • Annual subscription with implementation and integration scoped per site

Which should you pick?

Choose Ibex Medical Analytics if

  • You need ibex breast suite.
  • You work on Web, Cloud, On-premise.
  • You also want ibex prostate.
Ibex Medical Analytics review

Choose Rad AI if

  • You need impressions.
  • You work on Windows, Web, Cloud.
  • You also want reporting.
Rad AI review

Questions people ask

Is Ibex Medical Analytics or Rad AI better?
Neither clearly leads. Ibex Medical Analytics starts at On request and Rad AI at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Ibex Medical Analytics or Rad AI?
Ibex Medical Analytics starts at On request and Rad AI at On request.
Does Ibex Medical Analytics or Rad AI run on more platforms?
Ibex Medical Analytics runs on Web, Cloud, On-premise. Rad AI runs on Windows, Web, Cloud.
What is Ibex Medical Analytics best used for?
Ibex Medical Analytics is most often used for a histopathology department that cannot recruit and wants an automated safety net on every prostate and breast biopsy before sign out, a private laboratory group standardising gleason grading across pathologists with known interobserver variability, a service digitising histopathology that needs a clinical governance argument to justify the scanning programme to its board, a gastrointestinal service wanting helicobacter pylori detection automated so pathologists spend their time on the neoplastic cases. Of those, a histopathology department that cannot recruit and wants an automated safety net on every prostate and breast biopsy before sign out and a private laboratory group standardising gleason grading across pathologists with known interobserver variability are not what Rad AI is typically brought in for.
What can Ibex Medical Analytics do that Rad AI cannot?
Ibex Medical Analytics covers Ibex Breast Suite, Ibex Prostate, Ibex Gastric, Second read safety net. Rad AI covers Impressions, Reporting, Continuity, Style learning.

Answered from the vendors’ own pages

Ibex Medical Analytics: Is Ibex FDA cleared?

The regulatory position differs by product and market. In Europe the products carry CE marking under IVDR for defined diagnostic indications; in the United States some applications are used under laboratory developed test arrangements. Confirm the exact status for the specific application and market before assuming it can influence a signed report.

Rad AI: Is Rad AI FDA cleared?

No, and by design. The products draft text and manage follow-up workflow rather than interpreting images, so they fall outside the device pathway. Treat any diagnostic accuracy claim with scepticism.

Ibex Medical Analytics: Second read or prescreening?

Both are supported. Second read as a safety net is the more common clinical governance justification; prescreening is the efficiency case.

Rad AI: Does the radiologist still sign the report?

Yes. Output is a draft that the radiologist reviews and signs; nothing is released autonomously.

Ibex Medical Analytics: Does it need a particular scanner?

It ingests from the major whole slide scanner vendors rather than requiring a single fleet, which is a practical advantage over vendors tied to one scanner.

Rad AI: Which product actually pays for itself?

Continuity has the clearest financial case, because recommended follow-up imaging that gets completed is billable work that currently does not happen.

Ibex Medical Analytics: What tissue types are covered?

Breast, prostate and gastric. Everything else in the case mix is unsupported.

Rad AI: Will it work with our dictation system?

It is deepest with Nuance PowerScribe. Confirm your specific dictation and PACS combination before contracting, because integration depth is the main deployment variable.

Share

Related pages

More on Ibex Medical Analytics

More on Rad AI

Keep looking

Other head to heads